CD8A and melanoma: To illustrate in silico model-based inference in the context of cancer immunotherapy, we developed a multi-scale mechanistic model to describe the control of tumor growth by a primary response of CD8+ T cells against defined tumor antigens using the B16 mouse model for malignant melanoma (Ya et al., 2015).